InsidersTradesSigma
Track the 東和薬品株式会社 share price and the full management transaction log of the company, a listed equity based in Japan. Shares are quoted on the JP market, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, 東和薬品株式会社 has recorded 3 reports. Market capitalisation: €186.3bn. The latest transaction was disclosed on 6 July 2026 (Holding update). Among the most active insiders: Sumitomo Mitsui DS Asset Management Company, Limited. Every trade is openly available.
Analysts rate 東和薬品株式会社 Strong Buy (bullish), based on 6 analysts. Average price target: JP¥5,233.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Towa Pharmaceutical Co., Ltd. 是一家日本公司，专注于制药领域。其业务重点是药品的研发和营销。